Ads
related to: biogen
Search results
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
Yahoo Finance· 19 hours agoLilly's results showed a 35% reduction in progress of the disease in 18 months. The only other drug...
Eli Lilly's Alzheimer's drug gets backing from FDA advisers
Morningstar· 19 hours agoEli Lilly & Co.'s experimental Alzheimer's drug donanemab on Monday moved a step closer to U.S. regulatory approval as it won support from an independent panel of advisers to the Food and Drug ...
Apple Joins A.I. Race; Lilly Thumbs-Up on Alzheimer's Drug
Zacks via Yahoo Finance· 18 hours agoConsidering how many Apple products there are out there in the world at this time, a high number of...
Why Is Beam Therapeutics (BEAM) Up 10.1% Since Last Earnings Report?
Zacks via Yahoo Finance· 5 days agoPerformance of an Industry Player Beam Therapeutics belongs to the Zacks Medical - Biomedical and...
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to...
Morningstar· 6 days agoThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. (“Biogen” or “the Company ...
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters via AOL· 5 days agoBiopharma developer Samsung Bioepis, biotechs Biogen and Genentech, and Novartis, and some of their...
FDA panel backs Eli Lilly’s Alzheimer’s drug
The Hill· 17 hours agoA federal advisory panel on Monday voted in favor of recommending Eli Lilly’s new drug that is under consideration for its potential to slow the...
US medical advisers vote to recommend Eli Lilly Alzheimer drug
Medical Xpress· 7 hours agoAn independent panel of US medical experts voted Monday to recommend Eli Lilly's experimental Alzheimer's drug, meaning there could soon be another treatment option available to patients with ...
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks· 5 days agoGSK and Biogen (BIIB) are in the spotlight following litigation updates and drug approval,...
Eli Lilly Is Trading At A Record High Ahead Of A Key FDA Meeting — Is It A Buy?
Investor's Business Daily· 4 days agoDonanemab works by removing built-up plaque in the brain, known as beta amyloid. Doing leads can...